ClinicalTrials.Veeva

Menu

Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis

M

Mansoura University

Status

Completed

Conditions

Otomycosis

Treatments

Drug: Boric acid
Drug: Povidone iodine 10%

Study type

Interventional

Funder types

Other

Identifiers

NCT07295210
MS.24.12.3007

Details and patient eligibility

About

This study compares two topical agents for the treatment of fungal infection of the external auditory canal: boric acid and a 10% povidone-iodine solution

Enrollment

60 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all consecutive patients with otomycosis, recruited from the outpatient clinic during the study duration

Exclusion criteria

  • tympanic membrane perforation
  • previous ear surgery
  • significant medical co-morbidities such as poorly controlled diabetes or immunocompromised patients
  • patient refusal to participate in the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Boric acid group
Active Comparator group
Treatment:
Drug: Boric acid
Povidone iodine group
Active Comparator group
Treatment:
Drug: Povidone iodine 10%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems